Skip to main content
Clinical Trials/NCT02578342
NCT02578342
Completed
Not Applicable

Brain Activity and Functional Connectivity in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) During Tasks of Motor Inhibition and Cognitive Switching

Kantonsspital Aarau1 site in 1 country45 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor
Kantonsspital Aarau
Enrollment
45
Locations
1
Primary Endpoint
Changes in blood oxygenation level dependency (BOLD)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aim of the study is to investigate the response on cognitive testing of healthy persons compared to adults with or without medication against ADHD.

Detailed Description

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent psychiatric disorders in children and adolescents. It is characterized by inattentive, hyperactive, impulsive behaviour and neuropsychological deficits. In 40-60% of cases emerge in childhood and persists into adulthood. The aim of the study is to investigate the response on cognitive testing of healthy persons compared to adults with or without medication against ADHD. As a secondary endpoint a more robust diagnosing method combining advanced imaging methods with neuropsychological evaluation is tested. Neuropsychological testing, functional MRI and spectroscopy will be performed. Statistical analysis will assess differences in the functional magnetic resonance imaging, spectroscopy and neuropsychological evaluation results between three groups: 1) group of healthy volunteers, 2) participants with ADHD with medication and 3) participants with ADHD without medication.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
November 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kantonsspital Aarau
Responsible Party
Principal Investigator
Principal Investigator

Luca Remonda

Prof. Dr. med.

Kantonsspital Aarau

Eligibility Criteria

Inclusion Criteria

  • Participant is between 20-55 years old
  • Participant is not pregnant

Exclusion Criteria

  • Participant is not able to consent him/herself
  • Suspected or proven pregnancy
  • Neurological diseases that could interfere with a diagnosis of ADHD
  • Psychiatric comorbidity under treatment
  • Previous history of psychiatric medication
  • Substance abuse
  • Intelligence quotient\<75
  • Claustrophobia
  • Electrical simulator nerve or bone
  • Implanted medication infusion pump

Outcomes

Primary Outcomes

Changes in blood oxygenation level dependency (BOLD)

Time Frame: 2 hours

The study consist solely of one MRI examination performed within 2 hours.

Study Sites (1)

Loading locations...

Similar Trials